Number of the records: 1
Kaposiho sarkóm
SYS d012514 LBL 00000nz--a2200000o--4500 005 20250606213405.9 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a C01.925.256.466.860 065 $a C04.557.450.795.850 065 $a C04.557.645.750 066 $a 01 $c 03 089 $a 616-006.3.04 150 $a Kaposiho sarkóm $x BL $x BS $x CF $x CH $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SC $x SU $x TH $x UL $x UR $x VE $x VI $2 slo 450 $w v $a Kaposi Sarcoma $2 eng 665 $a 98; was SARCOMA, KAPOSI'S 1963-97; KAPOSI SARCOMA was KAPOSI'S SARCOMA 1963-97 $2 eng 680 9-
$i A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause. $2 eng 680 $a coordinate IM with precoordinated organ/ neoplasm term (IM) $2 eng 750 -2
$a Sarcoma, Kaposi $2 eng 980 $x M
Number of the records: 1